Du
Duke Cancer
NPDurham NCFounded 19724,000 employees
Private CapacadPrivateOncology
Platform: Cancer Ctr
Market Cap
N/A
All Drugs
5
Clinical Trials
5
Failed / Terminated
1
FDA Approved
3
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DUK-IIT-613 | DUK-IIT-613 | Approved | 1 | WRN | Psoriasis | ||
| DUK-IIT-640 | DUK-IIT-640 | NDA/BLA | 1 | TIM-3 | MCL | ||
| DUK-IIT-769 | DUK-IIT-769 | Approved | 1 | BCL-2 | ALS | ||
| DUK-IIT-634 | DUK-IIT-634 | Approved | 1 | CD20 | Schizophrenia | ||
| DUK-IIT-581 | DUK-IIT-581 | Phase 2 | 1 | APOC3 | Gastric Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)